All Oncology News

The OncLive® News page includes the latest in clinical oncology news, including breaking regulatory decisions, clinical trial findings, pivotal and practice-changing data published in academic peer-reviewed journals, and more across solid and hematologic malignancies. Regulatory news includes new drug approvals by the FDA and European Union, priority review and breakthrough therapy designations, and orphan drug and fast track statuses.

Adverse Drug Events

November 29th 2011

Four commonly prescribed drugs are responsible for most emergency room visits.

FDA Says Avastin Not Safe or Effective for Patients With Breast Cancer

November 18th 2011

The FDA commissioner announced the withdrawal of its approval for bevacizumab (Avastin) to treat patients with breast cancer.

FDA Grants Orphan Drug Status to Erwinaze for Treatment of Acute Lymphoblastic Leukemia

November 18th 2011

The FDA granted orphan drug approval to Erwinaze (asparaginase Erwinia chrysanthemi) to treat acute lymphoblastic leukemia (ALL).

Ruxolitinib Gains FDA Approval for Bone Marrow Disease

November 17th 2011

The FDA approved ruxolitinib (Jakafi) as the first drug to specifically treat patients with myelofibrosis, a bone marrow disease.

World Diabetes Day 2011

November 15th 2011

On November 14th, World Diabetes Day, a look at the recent diabetes statistics are concerning.

Who Most Influences Lifestyle Choices?

November 8th 2011

Global study identifies who people turn to for health advice.

Cetuximab Approved by FDA for Patients With Late-Stage Head and Neck Cancer

November 7th 2011

Cetuximab (Erbitux) was approved by the FDA for treating patients with late-stage head and neck cancer in combination with chemotherapy.

Updated Lung Cancer Screening Guidelines Released

November 1st 2011

The National Comprehensive Cancer Network releases newest update.

Metastatic Colorectal Cancer Study Demonstrates Improved Overall Survival

October 26th 2011

A late phase metastatic colorectal cancer trial was stopped after demonstrating a statistically significant improvement in OS.

Updated Cervical Cancer Screening Guidelines

October 24th 2011

Women are now advised to have fewer screenings over their lifetime.

Denosumab Delays Onset of Metastases in Castration-Resistant Prostate Cancer

October 18th 2011

Inhibiting the RANKL protein, which is involved in bone metabolism, can delay the onset of the bone metastases in men with castration-resistant prostate cancer.

Changing Fate of Bone-Related Therapies for Prostate Cancer

October 18th 2011

Two trials are underway that not only address bone-related issues but might improve survival rates for patients.

How's Your State Doing in Palliative Care?

October 17th 2011

The 2011 State-by-State Palliative Care Report Card is now available for viewing.

Vitamin E Supplements Linked to Increased Risk of Prostate Cancer

October 12th 2011

Vitamin E may increase the risk of developing prostate cancer in men who have taken the supplement for 5 years or longer.

Prostate Cancer Screening

October 10th 2011

The USPSTF releases its new recommendations for public comment.

Effectiveness of Adriamycin Questioned in the Treatment of Patients With HER2-Positive Breast Cancer

October 7th 2011

HER2-positive women can be effectively treated with Herceptin (trastuzumab injection) without the use of Adriamycin.

Welcome to UCD ChestHealth!

October 3rd 2011

Welcome to UCD ChestHealth, the official blog of UC Davis Thoracic Surgery.

Smoking Rates Released

October 3rd 2011

Do you know who has the highest---and lowest---smoking rates in the US?

New Frontiers in the Management of Solid and Liquid Tumors Letter from Andre Goy, MD, MS

October 1st 2011

A Letter from Andre Goy, MD, MS, about the New Frontiers in the Management of Solid and Liquid Tumors in November.

Compassionate Care

September 27th 2011

We may think we're delivering compassionate care, but the public feels otherwise.